← Open Payments lookup

SARA SCHUTT: Open Payments

NPI 1528661246 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$497 in 15 payments from 11 companies in 2025. Trend: 2023 $226 · 2024 $142 · 2025 $497

Food & beverage: $497
CompanyPaymentsAmount
Janssen Biotech, Inc.4$171
AstraZeneca Pharmaceuticals LP1$121
Novartis Pharmaceuticals Corporation2$42
Regeneron Healthcare Solutions, Inc.1$35
ABBVIE INC.1$32
Bayer Healthcare Pharmaceuticals Inc.1$18
SERVIER PHARMACEUTICALS LLC1$18
Aimmune Therapeutics, Inc.1$16
Genmab U.S., Inc.1$16
Daiichi Sankyo Inc.1$15

Products named: RYBREVANT, Epkinly, PLUVICTO, LYNOZYFIC, Nubeqa, Tibsovo, ZENPEP, Enhertu.

Industry payments across NE — which companies pay providers there.